• Extensive business experience within pharma commercial roles and management, the past 14 years at executive level with P&L responsibility. • Strong experience and excellent results from 25 years in pharma marketing, sales, communication, market access, medical and medicinal information. • Leadership of international projects with significant results. • Therapeutic areas: Oncology, hematology, immunology, rheumatology, pulmonology, diabetes, obesity, cardiovascular- and metabolic diseases, autoimmune diseases, virology, CNS, transplantation, anaemia, dermatology, gastroenterology and infection. • Since 2006 strong experience with biologic products (monoclonal antibodies). • Market access interaction with the public sector (RADS, KRIS and national tender). • The Danish Association of the Pharmaceutical Industry (Lif) representative. Mobile: +45 22172480 email: email@example.com
Board member Hørsholm, Denmark
Since April 2016
Parasite Technologies A/S is a biotech company developing a biological product for immune therapy and microbiome stimulation. Parasite Technologies is GMP-licensed by the Danish Medicines Agency (DMA) to produce the biological medicinal product TSO for further development into a pharmaceutical drug against autoimmune diseases. Approved by EMA and FDA for several clinical trials. The production is patent protected. Read more: www.para-tech.dk
Pharma- and Biotech Advisor and Facilitator, Partner
Since March 2015
KAPEL Consulting offers advice: With an extensive commercial, communication, market access and medical experience from the pharmaceutical industry and biotech, we can offer services across a broad range of therapeutic areas such as oncology/haematology, immunology, pulmonology, virology, gastroenterology, dermatology, diabetes, CVD, obesity, osteoporosis, CNS, anaemia, transplantation, infection and allergy. Interim Management & Project Management Business and Medical Strategy Plan • Product optimization, development of goals and strategies • Analysis of the commercial potential, the patient flow and market scenarios • Market research and competitive intelligence • Pricing and market access strategy • Plan of Action – closing the knowledge gaps • Performance Management Dashboard for Performance Management Product Launch Optimization Strategic advice on market access • RADS Stakeholders Analysis Plan • Advise and facilitate the ongoing RADS process • RADS Report and Presentation for the Clinical Committee Development of scientific marketing material • Proofreading of scientific marketing material according ENLI • Artwork and print of the final material Commercial- and Medical SOP writing or adaptation Therapeutic Areas experience: • Oncology/Haematology • Autoimmune diseases Rheumatology: Rheumatoid arthritis (RA), JIA, systemic JIA; Wegener’s. Multiple Sclerosis (MS); Lupus Nephritis, SLE • Gastroenterology Inflammatory bowel disease (IBD): Crohn’s Diseases and Ulcerative Colitis; Ulcers, GERD • Pulmonology Idiopathic Pulmonary Fibrosis (IPF); Cystic Fibrosis; Asthma • Diabetes • Obesity • Cardiovascular diseases • Osteoporosis • Virology Hepatitis HCV and HBV; HIV; Influenza • CNS Parkinson Diseases; Schizophrenia; Alzheimer's • Transplantation • Anaemia • Dermatology • Infection • Allergy Contact: KAPEL Consulting ApS Dr Neergaards Vej 3 Scion DTU DK-2970 Hørsholm CVR 34207755 Mobile: +45 22172480 e-mail: firstname.lastname@example.org
Business Unit Director, Speciality Care & Hematology
October 2011 --- February 2015
Denmark & Iceland. Reporting to the General Manager. Member of the Management Group in Roche a/s. Responsible for Marketing, Sales and Communication in one of the 2 Business Units in Roche: Marketing Managers, Sales Manager, Product Managers, Assisting Product Managers, Team Coordinators, Hospital Product Specialists, Digital Specialist, Communication Manager and RADS Project Manager (Market Access). Full P&L responsible. Integration Lead for the integration of the acquired company InterMune (2014). Champion for roll-out Symphony (2013). Lead of RoActemra Acceleration Growth Initiative (RAGI) for 17 West European countries (2010-2012). Steering Committee member for RoActemra Global Taskforce (2011-2012). Marketing excellence leader, Denmark. The Danish Association of Pharmaceutical Industry (Lif) representative. Therapy areas: Oncology/hematology, immunology, rheumatology, pulmonology (cystic fibrosis, IPF), virology (hepatitis B and C), transplantation, influenza, anaemia (EPO). Pipeline: Chronic lymphocytic leukaemia, non-Hodgkin’s lymphoma, diabetes, cardiovascular diseases, atherosclerosis, multiple sclerosis, schizophrenia, Alzheimer's disease, asthma.
April 2004 --- September 2011
Denmark & Iceland. Reporting to the General Manager. Member of the Management Group in Roche a/s. Responsible for Marketing Managers, Product Managers, Assisting Product Managers, Marketing Assistants. P&L responsible. Lead of Initiative for 17 West European countries (2010-2012). Steering Committee member for RoActemra Global Taskforce (2011-2012). Lead of Nordic GLP-1 Diabetes Project (2010). Lead of co-promotion Bonviva Task Force with GSK (osteoporosis). Therapeutic areas: Oncology/hematology, rheumatology, virology (hepatitis B and C), obesity, transplantation, influenza, cystic fibrosis, osteoporosis, HIV, anaemia (EPO), obesity. Pipeline: Chronic lymphocytic leukaemia, non-Hodgkin’s lymphoma, Type 2 Diabetes, cardiovascular diseases, atherosclerosis, multiple sclerosis, schizophrenia, hepatitis.
January 2001 --- March 2004
Denmark & Iceland. Reporting to the General Manager. Member of the Management Group in Roche a/s. P&L responsible. Responsible for Product Managers, Medical Manager, Medical Information and PR, Marketing Assistants, Sales Manager, GP Sales Force and a call-centre (Weight Management Program) with dieticians. Nordic coordinator for osteoporose (1998-2005).
Marketing Co-ordinator (Open Care)
January 2000 --- January 2001
Denmark & Iceland. Reporting to the Marketing Manager. Marketing Co-ordinator (Open Care) Roche a/s – and Product Manager / Medical Manager in obesity. Acting department manager for 4 teams in cardiology, osteoporosis, obesity and dermatology/Parkinson’s disease/cystic fibrosis. Manager for call-centre (WMP) with dieticians. Nordic coordinator for osteoporose (1998-2005). Member of the IBT (International Business Team), osteoporosis (1998-2000)
January 1997 --- January 2000
Product Manager Roche a/s: obesity (from July 2000) – Medical responsible for obesity. Product Manager: osteoporosis, dermatology, cystic fibrosis etc. (1997-2000). Member of the IBT (International Business Team), Basel, osteoporosis (1998-2000). Nordic co-ordinator for osteoporosis (1998-2005).
January 1993 --- January 1997
Rx: Gastroenterology (launched Pantoloc), infections, asthma/allergy, cough etc.
January 1992 --- January 1993
Product responsible for the antibiotic products and the diagnostic bedside tests NycoCard
Rx Sales rep
January 1991 --- January 1992
Cardivascular disease and obesity
Diploma Program at Scandinavian International Management Institute (SIMI - now CBS Executive) in Managing Medical Sales & Marketing (MMSM) from CBS Executive in 2002
M.Sc. Pharm. in Pharmacy from University of Copenhagen in 1991
High School Diploma in mathematics-physics from Sorø Akademi in 1984
Training and Certification
Board Certificate Certification
Saville Consulting Wave Professional Styles and Focus Styles Certification